COX-2-IN-16
COX-2-IN-16 (compound 2b) is a potent, selective and orally active COX-2 inhibitor with an IC50 of 102 μM. COX-2-IN-16 inhibits the NO production. COX-2-IN-16 shows anti-inflammatory activity[1].
Product Specifications
CAS Number
[1610894-92-2]
UNSPSC
12352005
Target
COX
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cox-2-in-16.html
Solubility
10 mM in DMSO
Smiles
O=[N+](C1=CC=C(C=C1)N2C3=CC=CC=C3N=C2C4=CC=C(C=C4)Br)[O-]
Molecular Formula
C19H12BrN3O2
Molecular Weight
394.22
References & Citations
[1]García-Aranda MI, et al. Anti-inflammatory effect and inhibition of nitric oxide production by targeting COXs and iNOS enzymes with the 1,2-diphenylbenzimidazole pharmacophore. Bioorg Med Chem. 2020 May 1;28 (9) :115427.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
COX-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6335751-01 0.2 mL
POLR2H, ID (POLR2H, DNA-directed RNA polymerases I, II, and III subunit RPABC3, DNA-directed RNA polymerase II subunit H, DNA-directed RNA polymerases I, II, and III 17.1kD polypeptide, RPB17, RPB8 homolog) (PE)
Ask
View Details 
MBS6335751-02 5x 0.2 mL
POLR2H, ID (POLR2H, DNA-directed RNA polymerases I, II, and III subunit RPABC3, DNA-directed RNA polymerase II subunit H, DNA-directed RNA polymerases I, II, and III 17.1kD polypeptide, RPB17, RPB8 homolog) (PE)
Ask
View Details 
NBP2-72562JF646 0.1 mL
Mouse Monoclonal MAB21L3 Antibody (OTI2A3) [Janelia Fluor 646]
Ask
View Details